Clinical trial
Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial
NCT06968429 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 31, 2025
- Completion date
- December 31, 2028
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
migraine